-
Medical journals
- Career
Articles on this topicSartans in the Treatment of Hypertension
Candesartan is beneficial in heart failure with mildly reduced ejection fraction
Analysis of data from the CHARM study showed that in patients with heart failure with mildly…19. 4. 2021 Source: Sartans in the Treatment of Hypertension
Candesartan Could Ameliorate the Cytokine Storm in COVID-19 Infection
Scientists from Bethesda, USA, experimentally found the upregulation of the same genes during…27. 1. 2021 Source: Sartans in the Treatment of Hypertension
Fixed Combination of Candesartan/Amlodipine in the Treatment of Arterial Hypertension
Arterial hypertension is a significant cardiovascular risk factor. A variety of…19. 1. 2021 Source: Sartans in the Treatment of Hypertension
Adequate Compensation of a Hypertensive Patient According to Current ESC Guidelines – Case Study
A 65-year-old man, hypertensive, visits the general practitioner for a check-up. He reports recent...29. 9. 2020 Source: Sartans in the Treatment of Hypertension
About Sartans: An Overview with Consideration of Their Position in the Current Coronavirus Situation
Sartans, or AT1 receptor blockers for angiotensin II (ARBs), are among the first-line…26. 5. 2020 Source: Sartans in the Treatment of Hypertension
Combination of Candesartan with ACE Inhibitors in the Treatment of Hypertension and Heart Failure
Although the combination of ACE inhibitors and sartans is not recommended due to the higher…25. 5. 2020 Source: Sartans in the Treatment of Hypertension
Development of Albuminuria During Treatment with ACE Inhibitors and Sartans
Individual molecules from the class of renin-angiotensin system inhibitors display various…25. 5. 2020 Source: Sartans in the Treatment of Hypertension
Impact of Candesartan on Achieving Remission in Patients with Active IgA Nephropathy
IgA nephropathy is the most common glomerulonephritis worldwide and in the Czech Republic. The…18. 4. 2020 Source: Sartans in the Treatment of Hypertension
Impact of Lifestyle on the Benefit of Pharmacotherapy for Hypertension and Dyslipidemia
Antihypertensive and hypolipidemic therapy reduces the risk of cardiovascular (CV) diseases.…18. 4. 2020 Source: Sartans in the Treatment of Hypertension
Could candesartan counteract adverse intestinal changes induced by hypertension?
An experimental study published last year was the first to show that administration of…6. 3. 2020 Source: Sartans in the Treatment of Hypertension
Effects of Telmisartan on Vascular Endothelial Functions, Inflammation Parameters, and Insulin Resistance in Patients with CHD and DM
Patients with coronary heart disease (CHD) and diabetes mellitus (DM) often have dysfunctional…2. 3. 2020 Source: Sartans in the Treatment of Hypertension
Metabolic Effect of Telmisartan and Candesartan in Kidney Transplant Patients
Increasing cardiovascular risk from complex causes warrants a comprehensive intervention. A…2. 3. 2020 Source: Sartans in the Treatment of Hypertension
1 2LoginSubscribe
E-courses on this topic
Most read on this topic- About Sartans: An Overview with Consideration of Their Position in the Current Coronavirus Situation
- Fixed Combination of Candesartan/Amlodipine in the Treatment of Arterial Hypertension
- Adequate Compensation of a Hypertensive Patient According to Current ESC Guidelines – Case Study
- Telmisartan – antihypertensive with cardioprotective effects
- Candesartan Could Ameliorate the Cytokine Storm in COVID-19 Infection
- Impact of ACEi and ARBs on Lung Function in Patients with Hypertension
Journal on this topic
Related topic
Interesting linksLogin#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career